Skip to search boxSkip to navigationSkip to main content

Innovative Approaches to Hypertension Control in Low- and Middle-Income Countries

  • Rajesh Vedanthan
    ,
  • ,
  • Omarys I. Herasme
    ,
  • Rohina Joshi
    ,
  • Patricio Lopez-Jaramillo
    ,
  • Amanda G. Thrift
  • Icahn School of Medicine at Mount Sinai
    ,
  • Universidad Peruana Cayetano Heredia
    ,
  • University of Sydney
    ,
  • Research Institute FOSCAL
    ,
  • Monash University
    ,
  • Queen's University, School of Medicine
Research Output:
Contribution to journal
Review article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Review article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 99-115 (17 pages)

Journal (Volume, Issue Number)

Cardiology Clinics (Volume 35, Issue 1)

Publication milestones

  • Published - 01/02/2017

Publication status

Published - 01/02/2017

ISSN

0733-8651

Publication IDs

  • Scopus: 84996993001
  • PubMed: 27886793

Abstract

Elevated blood pressure, a major risk factor for ischemic heart disease, heart failure, and stroke, is the leading global risk for mortality. Treatment and control rates are very low in low- and middle-income countries. There is an urgent need to address this problem. The Global Alliance for Chronic Diseases sponsored research projects focus on controlling hypertension, including community engagement, salt reduction, salt substitution, task redistribution, mHealth, and fixed-dose combination therapies. This paper reviews the rationale for each approach and summarizes the experience of some of the research teams. The studies demonstrate innovative and practical methods for improving hypertension control.

Funding Details

The writing group thanks Gary Parker from the GACD Secretariat for invaluable logistical and administrative support, and Drs Clara Chow, Pallab Maulik, and Martin McKee for critical review of the article. They also thank all members of the GACD Hypertension Research Program for their support and input throughout the preparation of this article. Funding for the studies described and for article submission was provided by the following GACD Hypertension Program funding agencies: Canadian Institutes of Health Research (Grant No. 120389 ); Grand Challenges Canada (Grant Nos. 0069-04 , and 0070-04 ); International Development Research Centre ; Canadian Stroke Network ; Australian National Health and Medical Research Council (Grant Nos. ID 1040147 , 1040030, 1041052, 104179, and 104018 ); the US National Institutes of Health (National Heart, Lung and Blood Institute and National Institute of Neurological Disorders and Stroke) (Grant Nos. U01 HL114200 , U01 NS079179 , and U01 HL114180 ); the United Kingdom Medical Research Council (Grant Nos. APP 1040179 , APP 1041052 , and J01 60201 ); and the Malaysian Ministry of Higher Education (Long-term Research Grants Scheme 600-RMI/LRGS/5/3). This report does not represent the official view of the National Institute of Neurological Disorders and Stroke, the National Institutes of Health, or any part of the US Federal Government. No official support or endorsement of this article by the National Institutes of Health is intended or should be inferred.
FundersFunding numbers
Australian National Health and Medical Research Council
1040147, 104179, 104018, 1041052, 1040030
Malaysian Ministry of Higher Education
600-RMI/LRGS/5/3
US National Institutes of Health
-
United Kingdom Medical Research Council
APP 1040179, APP 1041052, J01 60201
NHLBI
U01HL114180
NINDS
U01 NS079179, U01 HL114200
CSN
-
CIHR
120389
IDRC
-
Grand Challenges Canada
0069-04, 0070-04